Mechanisms of action of TNF-α and IL-6 in cancer pain
Cancer pain is a prevalent and often treatment-resistant complication of advanced cancer, highlighting the need for mechanism-based non-opioid targets. Inflammation within the tumor microenvironment is central to cancer pain, with TNF-α and IL-6 consistently implicated across preclinical models. However, these cytoki...